Login to Your Account



Clinic Roundup


Tuesday, September 24, 2013

• BG Medicine Inc., of Waltham, Mass., said results of a research study conducted at the Massachusetts General Hospital provided additional evidence that elevated levels of galectin-3 predict adverse outcomes in chronic heart failure and suggested the prognostic value of the noninvasive biomarker may be enhanced when serial measurements are made over time.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription